Evidence map›Paper›PMID 36322741›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

IER3IP1 is critical for maintaining glucose homeostasis through regulating the endoplasmic reticulum function and survival of β cells.

Jing Yang, Jinyang Zhen, Wenli Feng, Zhenqian Fan, Li Ding, Xiaoyun Yang, Yumeng Huang, Hua Shu, Jing Xie, Xin Li and 9 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Essential requirement for IER3IP1 in B cell development.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Jing YangDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Jinyang ZhenDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Wenli FengDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Zhenqian FanDepartment of Endocrinology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Li DingDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Xiaoyun YangDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Yumeng HuangDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.ORCID 0000-0002-6818-2168
Hua ShuDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Jing XieDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Xin LiDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.ORCID 0000-0001-6695-9044
Jingting QiaoDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.ORCID 0000-0002-1245-5411
Yuxin FanDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Jinhong SunDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Na LiDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Tengli LiuOrgan Transplant Center, Tianjin First Central Hospital, Nankai University, Tianjin 300192, China.
Shusen WangOrgan Transplant Center, Tianjin First Central Hospital, Nankai University, Tianjin 300192, China.
Xiaona ZhangDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Peter ArvanDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI 48105.ORCID 0000-0002-4007-8799
Ming LiuDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.ORCID 0000-0003-2665-4072
Tianjin Medical University General Hospital · CNNankai University · CNSecond Hospital of Tianjin Medical University · CNUniversity of Michigan · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Proinsulin Trafficking for Insulin BiosynthesisR01DK048280 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1994 to 2024
$10.5M
NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK048280
6 · The paper itself

Abstract

Recessive mutations in IER3IP1 (immediate early response 3 interacting protein 1) cause a syndrome of microcephaly, epilepsy, and permanent neonatal diabetes (MEDS). IER3IP1 encodes an endoplasmic reticulum (ER) membrane protein, which is crucial for brain development; however, the role of IER3IP1 in β cells remains unknown. We have generated two mouse models with either constitutive or inducible IER3IP1 deletion in β cells, named IER3IP1-βKO and IER3IP1-iβKO, respectively. We found that IER3IP1-βKO causes severe early-onset, insulin-deficient diabetes. Functional studies revealed a markedly dilated β-cell ER along with increased proinsulin misfolding and elevated expression of the ER chaperones, including PDI, ERO1, BiP, and P58IPK. Islet transcriptome analysis confirmed by qRT-PCR revealed decreased expression of genes associated with β-cell maturation, cell cycle, and antiapoptotic genes, accompanied by increased expression of antiproliferation genes. Indeed, multiple independent approaches further demonstrated that IER3IP1-βKO impaired β-cell maturation and proliferation, along with increased condensation of β-cell nuclear chromatin. Inducible β-cell IER3IP1 deletion in adult (8-wk-old) mice induced a similar diabetic phenotype, suggesting that IER3IP1 is also critical for function and survival even after β-cell early development. Importantly, IER3IP1 was decreased in β cells of patients with type 2 diabetes (T2D), suggesting an association of IER3IP1 deficiency with β-cell dysfunction in the more-common form of diabetes. These data not only uncover a critical role of IER3IP1 in β cells but also provide insight into molecular basis of diabetes caused by IER3IP1 mutations.

Indexed as

Diabetes Mellitus, Type 2Insulin-Secreting CellsAnimalsEndoplasmic ReticulumGlucoseHomeostasisMiceGlucosediabetesER stressIER3IP1β cell proliferationβ cell survival

Identifiers

PMID36322741
PMCPMC9659391
OpenAlexW4308146091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.